SBIR Phase II: Innovative Protein Microarrays

SBIR 第二阶段：创新蛋白质微阵列

• 批准号: 0349712
• 负责人: Andrzej Drukier
• 金额: $ 49.98万
• 依托单位: BioTraces Inc
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-02-01 至 2008-01-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0349712&HistoricalAwards=false
• 关键词: SBIR; Phase; II; Innovative; Protein

0349712DrukierThis Small Business Innovation Research Phase II project proposes to develop a novel supersensitive multiphoton detection system for protein chips (P-chip/MPD) for applications in drug discovery and in early detection of prostate cancer and breast cancer. The commercial impact of the proposed work will be in the area of diagnostic proteomics. The diagnostics industry is large, currently estimated at around 10 billion dollars per year. The most profitable and dynamically growing fields are those that permit early detection of cancer and therapy monitoring, or provide toxicity assays for new drugs. It is expected that the P-Chips/MPD developed in this project will eventually capture a significant share of the diagnostic proteomics market.

0349712Drukier这个小企业创新研究第二阶段项目建议开发一种新型的超灵敏蛋白质芯片多光子检测系统(P-CHIP/MPD)，用于药物发现和前列腺癌和乳腺癌的早期检测。拟议工作的商业影响将在诊断蛋白质组学领域。诊断行业规模很大，目前估计每年约为100亿美元。最有利可图和动态增长的领域是那些允许癌症早期检测和治疗监测的领域，或者为新药提供毒性分析的领域。预计在该项目中开发的P-CHIP/MPD最终将在诊断蛋白质组学市场占据相当大的份额。